Superworth

Emergent BioSolutions PE ratio EBS

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026
n/m
losses over the last year
Last meaningful
9.6×
Apr 2026
10-year median
26.0×
10-year range
3.1× to 84.9×
Peer median
11.5×

Emergent BioSolutions has no meaningful PE ratio today: it lost $3.55 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Apr 2026, at 9.6×.

On the days it had one over the last ten years, its median was 26.0×, from 3.1× in Sep 2025 to 84.9× in Jul 2020.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far9.6×8.3×10.5×
20259.6×3.1×9.6×
2024n/m a value too high to mean anything
202316.7×15.9×19.9×
202214.4×8.5×19.2×
202110.3×6.0×40.1×
202028.7×26.5×84.9×
201954.8×30.0×59.6×
201829.9×24.7×40.4×
201726.0×21.1×35.0×
201633.2×15.0×36.2×
201533.3×29.0×62.5×
201458.2×26.3×71.1×
201327.0×15.9×29.3×
201216.2×13.4×18.5×

Against its peers

Companies in Drug Manufacturers - General nearest Emergent BioSolutions' size, closest first, today.

CompanyPE ratio
EBSEmergent BioSolutionsn/m
NATRNatures Sunshine Products12.0×
ARVNArvinas45.6×
PBYIPuma Biotechnology21.2×
IRWDIronwood Pharmaceuticals4.5×
ZVRAZevra Therapeutics10.5×
CRMDCorMedix3.7×
COLLCollegium Pharmaceutical18.5×
ABUSArbutus Biopharma5.4×
AMPHAmphastar Pharmaceuticals14.8×
OMEROmeros10.9×
Peer median11.5×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Emergent BioSolutions

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.